Vetoquinol: Dominique Derveaux Appointed Group Chief Operations Officer
28 Aprile 2020 - 5:45PM
Business Wire
Regulatory News:
Effective April 1, 2020, Vetoquinol’s (Paris:VETO) Board of
Directors has appointed Dominique Derveaux Group Chief Operations
Officer. In this capacity, he will run the Business, Marketing
& Medical, Industrial, and Information Systems departments. He
will report to Vetoquinol CEO Matthieu Frechin.
Dominique Derveaux graduated from SKEMA business school with a
major in advanced accounting and finance. In 1991, he began his
career in Germany as a financial controller, after which he held
various international business management positions in Europe and
Asia Pacific in the construction industry, mostly dealing with mass
market distribution channels.
Dominique Derveaux first joined Vetoquinol in August 2009 as
Director, Northern Europe. He was later appointed Group Director,
Europe in 2011 and took over the management of North America in
2015 to become Group Director, Europe and North America until March
31, 2020.
Matthieu Frechin said: “I am delighted with Dominique Derveaux’s
promotion to Chief Operations Officer. Since joining us 10 years
ago, Dominique has demonstrated his outstanding ability to run
Vetoquinol operations in Europe and North America. His talent is a
key asset for our company. I am sure that, on the strength of his
achievements and leadership qualities, he is capable of taking the
company to new heights of success. Lastly, I would like to thank
Jean-Yves Ravinet for his commitment and contribution to
Vetoquinol’s successful development over the past 7 years.”
Next update: Shareholders meeting, May 26, 2020 after
market close
About Vetoquinol Vetoquinol is a leading global animal
health company that supplies drugs and non-medicinal products for
the livestock (cattle and pigs) and pet (dogs and cats) markets. As
an independent pure player, Vetoquinol designs, develops and sells
veterinary drugs and non-medicinal products in Europe, the Americas
and the Asia Pacific region. Since its foundation in 1933,
Vetoquinol has pursued a strategy combining innovation with
geographical diversification. The Group's hybrid growth is driven
by the reinforcement of its product portfolio coupled with
acquisitions in high potential growth markets. At December 31 2019
Vetoquinol employs 2,372 people. Vetoquinol has been listed on
Euronext Paris since 2006 (symbol: VETO).
For further information, go to: www.vetoquinol.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20200428005675/en/
VETOQUINOL Corporate
Communication Xavier Berthet Tel.: +33 (0)3 84 62 58 77
xavier.berthet@vetoquinol.com
Investor Relations Fanny Toillon
Tel.: +33 (0)3 84 62 59 88
relations.investisseurs@vetoquinol.com
KEIMA Communication Investor and
Media Relations Emmanuel Dovergne Tel.: +33 (0)1 56 43 44 63
emmanuel.dovergne@keima.fr
Grafico Azioni Vetoquinol (EU:VETO)
Storico
Da Mar 2024 a Apr 2024
Grafico Azioni Vetoquinol (EU:VETO)
Storico
Da Apr 2023 a Apr 2024